Bala Kumaar is a strategic biotech executive with over 15 years of experience in the development and commercialization of biologics, mRNA, and ASOs. They currently serve as the Director of Asset Development & Portfolio Management at Biogen, where they lead end-to-end asset strategy and lifecycle management for pipeline programs in rare diseases. Previously, Bala was the Director of Process Development at Catalent Pharma Solutions and held roles at Amgen where they directed teams in process development for large molecule therapeutics. Bala is also pursuing a Ph.D. and an MS in Biochemistry from Arizona State University, further enhancing their expertise in the field.
This person is not in the org chart
This person is not in any teams
This person is not in any offices